Komipharm International Co., Ltd. (KOSDAQ:041960)

Komipharm International Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	650,353	267,413	293,942	446,056	548,450	858,749
Market Cap Growth	143.83%	-9.03%	-34.10%	-18.67%	-36.13%	-11.44%
Enterprise Value	665,819	289,788	324,970	476,056	565,527	878,631
Last Close Price	8990.00	3860.00	4190.00	6350.57	7804.20	12219.61
PE Ratio	-	20.39	-	-	-	-
PS Ratio	11.55	4.55	6.89	11.21	15.30	23.11
PB Ratio	8.69	4.08	4.90	6.80	7.58	11.00
P/TBV Ratio	9.26	4.43	5.22	7.36	8.26	11.27
P/FCF Ratio	-	34.28	-	-	-	-
P/OCF Ratio	427.62	30.23	-	-	-	34076.71
EV/Sales Ratio	11.83	4.93	7.62	11.96	15.78	23.64
EV/EBITDA Ratio	117.59	31.18	-	21308.58	-	561.53
EV/EBIT Ratio	258.30	46.79	-	-	-	-
EV/FCF Ratio	-1842.10	37.14	-	-	-	-
Debt / Equity Ratio	0.55	0.67	0.75	0.58	0.46	0.46
Debt / EBITDA Ratio	7.25	4.72	-	1706.78	-	22.80
Debt / FCF Ratio	-	5.62	-	-	-	-
Net Debt / Equity Ratio	0.17	0.33	0.51	0.42	0.27	0.24
Net Debt / EBITDA Ratio	2.23	2.30	-11.04	1223.16	-11.41	11.86
Net Debt / FCF Ratio	-34.87	2.74	-8.81	-10.29	-9.42	-11.38
Asset Turnover	0.42	0.49	0.37	0.35	0.30	0.30
Inventory Turnover	2.37	2.52	1.93	1.87	1.77	1.83
Quick Ratio	1.36	0.83	0.52	0.53	0.93	0.72
Current Ratio	2.03	1.30	0.96	1.01	1.61	1.14
Return on Equity (ROE)	-4.71%	23.40%	-9.41%	-10.84%	-7.89%	-5.13%
Return on Assets (ROA)	1.21%	3.21%	-3.40%	-2.09%	-2.79%	-1.10%
Return on Capital Employed (ROCE)	2.60%	8.10%	-9.50%	-5.40%	-5.90%	-2.60%
Earnings Yield	-0.39%	4.90%	-1.35%	-1.46%	-0.81%	-0.33%
FCF Yield	-0.06%	2.92%	-1.17%	-0.60%	-0.38%	-0.19%
Buyback Yield / Dilution	-1.54%	0.66%	0.18%	-0.01%	-0.09%	-0.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.